Eintrag weiter verarbeiten
Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II): extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgk...
Gespeichert in:
Veröffentlicht in: | Journal of clinical oncology 32(2014), 36, Seite 4127-4133 |
---|---|
Personen und Körperschaften: | , |
Titel: | Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II): extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group/ Pfreundschuh M., Poeschel V., Zeynalova S., Hänel M., Held G., Schmitz N., Viardot A., Dreyling M.H., Hallek M., Mueller C., Wiesen M.H., Witzens-Harig M., Truemper L., Keller U., Rixecker T., Zwick C., Murawski N. |
Format: | E-Book-Kapitel |
Sprache: | Englisch |
veröffentlicht: |
2014
|
Gesamtaufnahme: |
: Journal of clinical oncology, 32(2014), 36, Seite 4127-4133
, volume:32 |
Quelle: | Verbunddaten SWB Lizenzfreie Online-Ressourcen |
LEADER | 02217caa a2200493 4500 | ||
---|---|---|---|
001 | 0-1504042328 | ||
003 | DE-627 | ||
005 | 20220812004246.0 | ||
007 | cr uuu---uuuuu | ||
008 | 150619s2014 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1200/JCO.2013.54.6861 |2 doi | |
035 | |a (DE-627)1504042328 | ||
035 | |a (DE-576)434042323 | ||
035 | |a (DE-599)BSZ434042323 | ||
035 | |a (OCoLC)1340692110 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
245 | 1 | 0 | |a Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II) |b extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group |c Pfreundschuh M., Poeschel V., Zeynalova S., Hänel M., Held G., Schmitz N., Viardot A., Dreyling M.H., Hallek M., Mueller C., Wiesen M.H., Witzens-Harig M., Truemper L., Keller U., Rixecker T., Zwick C., Murawski N. |
264 | 1 | |c 2014 | |
300 | |a 7 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Gesehen am 19.06.2015 | ||
700 | 1 | |a Pfreundschuh, Michael |d 1949-2018 |0 (DE-588)108615871 |0 (DE-627)394701879 |0 (DE-576)289617227 |4 oth | |
700 | 1 | |a Witzens-Harig, Mathias |0 (DE-588)1050736516 |0 (DE-627)784812322 |0 (DE-576)404988970 |4 oth | |
773 | 0 | 8 | |i In |t Journal of clinical oncology |d Alexandria, Va. : American Society of Clinical Oncology, 1983 |g 32(2014), 36, Seite 4127-4133 |h Online-Ressource |w (DE-627)313116962 |w (DE-600)2005181-5 |w (DE-576)090887018 |x 1527-7755 |7 nnns |
773 | 1 | 8 | |g volume:32 |g year:2014 |g number:36 |g pages:4127-4133 |g extent:7 |
856 | 4 | 0 | |u http://dx.doi.org/10.1200/JCO.2013.54.6861 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
936 | u | w | |d 32 |j 2014 |e 36 |h 4127-4133 |g 7 |
951 | |a AR | ||
856 | 4 | 0 | |u http://dx.doi.org/10.1200/JCO.2013.54.6861 |9 LFER |
852 | |a LFER |z 2015-07-13T00:00:00Z | ||
970 | |c OD | ||
971 | |c EBOOK | ||
972 | |c EBOOK | ||
973 | |c Aufsatz | ||
935 | |a lfer | ||
900 | |a Witzens-Harig, M. | ||
900 | |a Harig, Mathias Witzens- | ||
900 | |a Harig, M. Witzens- | ||
900 | |a Witzens-Harig, Matthias | ||
900 | |a Witzens, M. | ||
980 | |a 1504042328 |b 0 |k 1504042328 |o 434042323 |c lfer |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Optimization+of+rituximab+for+the+treatment+of+diffuse+large+B-Cell+lymphoma+%28II%29%3A+extended+rituximab+exposure+time+in+the+SMARTE-R-CHOP-14+trial+of+the+German+High-Grade+Non-Hodgkin+Lymphoma+Study+Group&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rft.creator=&rft.pub=&rft.format=Journal&rft.language=English&rft.issn=1527-7755 |
---|
_version_ | 1757940074576609280 |
---|---|
access_facet | Electronic Resources |
author2 | Pfreundschuh, Michael, Witzens-Harig, Mathias |
author2_role | oth, oth |
author2_variant | m p mp, m w h mwh |
author_facet | Pfreundschuh, Michael, Witzens-Harig, Mathias |
callnumber-sort | |
collection | lfer |
container_reference | 32(2014), 36, Seite 4127-4133 |
container_title | Journal of clinical oncology |
ctrlnum | (DE-627)1504042328, (DE-576)434042323, (DE-599)BSZ434042323, (OCoLC)1340692110 |
doi_str_mv | 10.1200/JCO.2013.54.6861 |
facet_avail | Online, Free |
finc_class_facet | not assigned |
finc_id_str | 0017792720 |
footnote | Gesehen am 19.06.2015 |
format | ElectronicBookComponentPart |
format_access_txtF_mv | Article, E-Article |
format_de105 | Ebook |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_del152 | Buch |
format_detail_txtF_mv | text-online-monograph-child |
format_dezi4 | e-Book |
format_finc | Article, E-Article |
format_legacy | ElectronicBookPart |
format_strict_txtF_mv | E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
hierarchy_parent_id | 0-313116962 |
hierarchy_parent_title | Journal of clinical oncology |
hierarchy_sequence | 32(2014), 36, Seite 4127-4133 |
hierarchy_top_id | 0-313116962 |
hierarchy_top_title | Journal of clinical oncology |
id | 0-1504042328 |
illustrated | Not Illustrated |
imprint | 2014 |
imprint_str_mv | 2014 |
institution | DE-D117, DE-105, LFER, DE-Ch1, DE-15, DE-14, DE-Zwi2 |
is_hierarchy_id | 0-1504042328 |
is_hierarchy_title | Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II): extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group |
isil_str_mv | LFER |
issn | 1527-7755 |
kxp_id_str | 1504042328 |
language | English |
last_indexed | 2023-02-15T23:04:57.828Z |
marc024a_ct_mv | 10.1200/JCO.2013.54.6861 |
match_str | pfreundschuh2014optimizationofrituximabforthetreatmentofdiffuselargebcelllymphomaiiextendedrituximabexposuretimeinthesmarterchop14trialofthegermanhighgradenonhodgkinlymphomastudygroup |
mega_collection | Verbunddaten SWB, Lizenzfreie Online-Ressourcen |
misc_de105 | EBOOK |
multipart_link | 090887018 |
multipart_part | (090887018)32(2014), 36, Seite 4127-4133 |
names_id_str_mv | (DE-588)108615871, (DE-627)394701879, (DE-576)289617227, (DE-588)1050736516, (DE-627)784812322, (DE-576)404988970 |
oclc_num | 1340692110 |
physical | 7 |
publishDate | 2014 |
publishDateSort | 2014 |
publishPlace | |
publisher | |
record_format | marcfinc |
record_id | 434042323 |
recordtype | marcfinc |
rvk_facet | No subject assigned |
source_id | 0 |
spelling | Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II) extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group Pfreundschuh M., Poeschel V., Zeynalova S., Hänel M., Held G., Schmitz N., Viardot A., Dreyling M.H., Hallek M., Mueller C., Wiesen M.H., Witzens-Harig M., Truemper L., Keller U., Rixecker T., Zwick C., Murawski N., 2014, 7, Text txt rdacontent, Computermedien c rdamedia, Online-Ressource cr rdacarrier, Gesehen am 19.06.2015, Pfreundschuh, Michael 1949-2018 (DE-588)108615871 (DE-627)394701879 (DE-576)289617227 oth, Witzens-Harig, Mathias (DE-588)1050736516 (DE-627)784812322 (DE-576)404988970 oth, In Journal of clinical oncology Alexandria, Va. : American Society of Clinical Oncology, 1983 32(2014), 36, Seite 4127-4133 Online-Ressource (DE-627)313116962 (DE-600)2005181-5 (DE-576)090887018 1527-7755 nnns, volume:32 year:2014 number:36 pages:4127-4133 extent:7, http://dx.doi.org/10.1200/JCO.2013.54.6861 Verlag Resolving-System kostenfrei Volltext, http://dx.doi.org/10.1200/JCO.2013.54.6861 LFER, LFER 2015-07-13T00:00:00Z |
spellingShingle | Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II): extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group |
swb_id_str | 434042323 |
title | Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II): extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group |
title_auth | Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II) extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group |
title_full | Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II) extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group Pfreundschuh M., Poeschel V., Zeynalova S., Hänel M., Held G., Schmitz N., Viardot A., Dreyling M.H., Hallek M., Mueller C., Wiesen M.H., Witzens-Harig M., Truemper L., Keller U., Rixecker T., Zwick C., Murawski N. |
title_fullStr | Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II) extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group Pfreundschuh M., Poeschel V., Zeynalova S., Hänel M., Held G., Schmitz N., Viardot A., Dreyling M.H., Hallek M., Mueller C., Wiesen M.H., Witzens-Harig M., Truemper L., Keller U., Rixecker T., Zwick C., Murawski N. |
title_full_unstemmed | Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II) extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group Pfreundschuh M., Poeschel V., Zeynalova S., Hänel M., Held G., Schmitz N., Viardot A., Dreyling M.H., Hallek M., Mueller C., Wiesen M.H., Witzens-Harig M., Truemper L., Keller U., Rixecker T., Zwick C., Murawski N. |
title_in_hierarchy | Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II): extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group / Pfreundschuh M., Poeschel V., Zeynalova S., Hänel M., Held G., Schmitz N., Viardot A., Dreyling M.H., Hallek M., Mueller C., Wiesen M.H., Witzens-Harig M., Truemper L., Keller U., Rixecker T., Zwick C., Murawski N., |
title_short | Optimization of rituximab for the treatment of diffuse large B-Cell lymphoma (II) |
title_sort | optimization of rituximab for the treatment of diffuse large b cell lymphoma ii extended rituximab exposure time in the smarte r chop 14 trial of the german high grade non hodgkin lymphoma study group |
title_sub | extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group |
url | http://dx.doi.org/10.1200/JCO.2013.54.6861 |